MedSec's decision to warn investors was audacious and controversial because of a little-known, unwritten truce that exists between security researchers, who seek to discover and exploit weakness in cyber products, and vendors. Some commentators say MedSec broke the truce.
They're wrong. MedSec skirted a fine line, but blame rests squarely with St. Jude.
Read Full Article »